Literature DB >> 12695431

The obesity epidemic: can we turn the tide?

I Campbell1.   

Abstract

Obesity has reached epidemic proportions in the UK. It is important because of the associated co-morbidities, which include cardiovascular disease, type 2 diabetes, and osteoarthritis. The prevalence of obesity has increased because of a combination of excessive calorific intake (for example, from increased intake of energy dense foods) and insufficient energy expenditure (associated with a sedentary lifestyle). Weight loss of 5-10%, which can be achieved in primary care, is associated with significant health benefits. Obesity treatment in primary care includes lifestyle modification and drug treatment. The prevention and treatment of obesity cannot, however, be left solely to health professionals. Action is needed by government, the food industry, and society as a whole.

Entities:  

Mesh:

Year:  2003        PMID: 12695431      PMCID: PMC1876296          DOI: 10.1136/heart.89.suppl_2.ii22

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  PubMed Central: creating an Aladdin's cave of ideas.

Authors:  T Delamothe; R Smith
Journal:  BMJ       Date:  2001-01-06

2.  Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.

Authors:  R H Eckel
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

3.  The continuing epidemics of obesity and diabetes in the United States.

Authors:  A H Mokdad; B A Bowman; E S Ford; F Vinicor; J S Marks; J P Koplan
Journal:  JAMA       Date:  2001-09-12       Impact factor: 56.272

Review 4.  Obesity as a disease.

Authors:  R T Jung
Journal:  Br Med Bull       Date:  1997       Impact factor: 4.291

5.  Impairment of health and quality of life in people with large waist circumference.

Authors:  M E Lean; T S Han; J C Seidell
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

6.  Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

Authors:  J M Chan; E B Rimm; G A Colditz; M J Stampfer; W C Willett
Journal:  Diabetes Care       Date:  1994-09       Impact factor: 19.112

7.  Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range.

Authors:  W C Willett; J E Manson; M J Stampfer; G A Colditz; B Rosner; F E Speizer; C H Hennekens
Journal:  JAMA       Date:  1995-02-08       Impact factor: 56.272

  7 in total
  5 in total

1.  Single frequency bioelectrical impedance is a poor method for determining fat mass in moderately obese women.

Authors:  Veronica P Alvarez; John B Dixon; Boyd J G Strauss; Cheryl P Laurie; Timothy B Chaston; Paul E O'Brien
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

2.  Decreased bodyweight without rebound and regulated lipoprotein metabolism by gymnemate in genetic multifactor syndrome animal.

Authors:  Hong Luo; Akiko Kashiwagi; Toshiyuki Shibahara; Kazuo Yamada
Journal:  Mol Cell Biochem       Date:  2007-05       Impact factor: 3.842

3.  What's law got to do with it part 1: A framework for obesity prevention.

Authors:  Roger S Magnusson
Journal:  Aust New Zealand Health Policy       Date:  2008-06-05

4.  The creation of a healthy eating motivation score and its association with food choice and physical activity in a cross sectional sample of Irish adults.

Authors:  Paul Naughton; Sinéad N McCarthy; Mary B McCarthy
Journal:  Int J Behav Nutr Phys Act       Date:  2015-06-06       Impact factor: 6.457

5.  A community pharmacy weight management programme: an evaluation of effectiveness.

Authors:  David Morrison; Philip McLoone; Naomi Brosnahan; Louise McCombie; Andrea Smith; Janie Gordon
Journal:  BMC Public Health       Date:  2013-03-27       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.